Temocillin: is this the right momentum for its global use?

Future Microbiol. 2019 Jan:14:81-83. doi: 10.2217/fmb-2018-0316. Epub 2019 Jan 15.

Authors

Indran Balakrishnan¹, Vasiliki Koumaki², Athanasios Tsakris²

Affiliations

¹ Department of Medical Microbiology, Royal Free London NHS Foundation Trust, London, UK.
² Department of Microbiology, Medical School, University of Athens, Athens, Greece.

PMID: 30644315
DOI: 10.2217/fmb-2018-0316

No abstract available

Keywords: antibiotic resistance; carbapenemase; extended-spectrum β-lactamase; β-lactams.

Publication types

Editorial

MeSH terms

Anti-Bacterial Agents / therapeutic use*
Bacterial Proteins
Drug Resistance, Multiple, Bacterial / drug effects
Gram-Negative Bacteria / drug effects
Gram-Negative Bacteria / pathogenicity
Gram-Positive Bacteria / drug effects
Gram-Positive Bacteria / pathogenicity
Humans
Microbial Sensitivity Tests
Penicillins / therapeutic use*
beta-Lactamases
beta-Lactams / therapeutic use

Substances

Anti-Bacterial Agents
Bacterial Proteins
Penicillins
beta-Lactams
temocillin
beta-Lactamases
carbapenemase